[go: up one dir, main page]

WO2007067756A3 - Certains types d'entites chimiques, compositions et methode de modulation de trpv1 - Google Patents

Certains types d'entites chimiques, compositions et methode de modulation de trpv1 Download PDF

Info

Publication number
WO2007067756A3
WO2007067756A3 PCT/US2006/047002 US2006047002W WO2007067756A3 WO 2007067756 A3 WO2007067756 A3 WO 2007067756A3 US 2006047002 W US2006047002 W US 2006047002W WO 2007067756 A3 WO2007067756 A3 WO 2007067756A3
Authority
WO
WIPO (PCT)
Prior art keywords
chemical entities
compositions
methods
trpv1
certain chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/047002
Other languages
English (en)
Other versions
WO2007067756A2 (fr
Inventor
Jose S Mendoza
Carl Nicholas Hodge
John K Dickson Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amphora Discovery Corp
Original Assignee
Amphora Discovery Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amphora Discovery Corp filed Critical Amphora Discovery Corp
Publication of WO2007067756A2 publication Critical patent/WO2007067756A2/fr
Anticipated expiration legal-status Critical
Publication of WO2007067756A3 publication Critical patent/WO2007067756A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention porte sur des entités chimiques choisies parmi des composés de formule (I) et sur des sels acceptables d'un point de vue pharmaceutique ou cosmétique, des solvates, des chélates, des complexes non covalents, des promédicaments et des mélanges de ceux-ci. Les entités chimiques modulent TRPV1 et sont utiles dans le traitement d'au moins une maladie ou trouble modulé par l'activité de TRPV1.
PCT/US2006/047002 2005-12-08 2006-12-05 Certains types d'entites chimiques, compositions et methode de modulation de trpv1 Ceased WO2007067756A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74902005P 2005-12-08 2005-12-08
US60/749,020 2005-12-08

Publications (2)

Publication Number Publication Date
WO2007067756A2 WO2007067756A2 (fr) 2007-06-14
WO2007067756A3 true WO2007067756A3 (fr) 2009-04-16

Family

ID=38123535

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/047002 Ceased WO2007067756A2 (fr) 2005-12-08 2006-12-05 Certains types d'entites chimiques, compositions et methode de modulation de trpv1

Country Status (1)

Country Link
WO (1) WO2007067756A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7943666B2 (en) 2006-07-24 2011-05-17 Trinity Laboratories, Inc. Esters of capsaicin for treating pain
JP5643112B2 (ja) 2008-01-28 2014-12-17 アモーレパシフィック コーポレイションＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ バニロイド受容体としての新規化合物、その異性体または薬剤学的に許容し得る塩、及びこれを含有する医薬組成物
KR101621444B1 (ko) 2008-07-02 2016-05-19 (주)아모레퍼시픽 바닐로이드 수용체 길항제로 작용하는 신규 화합물, 이의 이성질체 또는 이의 약제학적으로 허용 가능한 염, 및 이를 포함하는 약학 조성물
JO3154B1 (ar) 2011-06-17 2017-09-20 Glaxosmithkline Llc عوامل مضادة لـ trpv4

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5500444A (en) * 1989-11-14 1996-03-19 Hoechst Marion Roussel, Inc. Cardioprotective tocopherol analogs
US20050019954A1 (en) * 2003-07-23 2005-01-27 Eastman Kodak Company Photochromic dyes for microsphere based sensor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5500444A (en) * 1989-11-14 1996-03-19 Hoechst Marion Roussel, Inc. Cardioprotective tocopherol analogs
US20050019954A1 (en) * 2003-07-23 2005-01-27 Eastman Kodak Company Photochromic dyes for microsphere based sensor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SHIN ET AL.: "Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia.", PNAS, vol. 99, no. 15, 23 July 2002 (2002-07-23), pages 10150 - 10155 *

Also Published As

Publication number Publication date
WO2007067756A2 (fr) 2007-06-14

Similar Documents

Publication Publication Date Title
WO2007067711A3 (fr) Certains types d'entites chimiques, compositions et methode de modulation de trpv1
WO2005005378A3 (fr) Hydrazides d'indolinone utilises en tant qu'inhibiteurs du recepteur c-met
WO2007024717A3 (fr) Agents permettant de prevenir et de traiter des troubles entrainant la modulation des recepteurs ryr
WO2005086661A3 (fr) Composes, compositions pharmaceutiques et procedes d'utilisation dans le traitement de troubles metaboliques
WO2005040116A3 (fr) Derives d'indolinone et utilisations de ceux-ci pour traiter des etats pathologiques tels que le cancer
WO2004080377A3 (fr) Nouveaux composes modulant le canal kcnq et leur utilisation
WO2008062276A8 (fr) Dérivés d'acétylène comme inhibiteurs de la stéaroyl coa désaturase
NO20082145L (no) Prolinamidderivater som natriumkanalmodulatorer
WO2005061452A8 (fr) Derives diphenylazetidinone a activite inhibitrice de l'absorption du cholesterol
ATE449604T1 (de) Pyrazolamid-derivate, diese verbindungen enthaltende zusammensetzungen und anwendungsverfahren
CY1112727T1 (el) Παραγωγα κυκλοβουτυλ αμινης βενζοθειαζολης και η χρηση αυτων ως προσδετες των υποδοχεων ισταμινης-3
WO2007062999A3 (fr) Derives de indole-2-yl amide substitues en 1,5
WO2005097788A3 (fr) Sulfonamides et utilisations de ceux-ci
WO2005080352A3 (fr) Derives de quinazoline et leur utilisation therapeutique
ATE472529T1 (de) Prolinamidderivate als natriumkanalmodulatoren
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
WO2009037542A3 (fr) Composés spirocycliques en tant qu'inhibiteurs de stéaroyle coa désaturase
MY148538A (en) Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
NO20054787D0 (no) Indenderivater som farmasotiske midler
WO2007131907A3 (fr) Dérivés de 1h-indol-5-yl-pipérazin-1-yl-méthanone
MXPA05013151A (es) 3-fluoro-piperidinas como antagonistas de n-metil-d-aspartato/nr2b.
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
IL229594A0 (en) Materials and preparations for the treatment of tumors
WO2006063294A3 (fr) Nouveaux inhibiteurs de l'histone deacetylase permettant de traiter une maladie
WO2007067756A3 (fr) Certains types d'entites chimiques, compositions et methode de modulation de trpv1

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06845091

Country of ref document: EP

Kind code of ref document: A2